Research Exchange
November 10 2014 Research involving Nottingham academics has shown that a signal protein that plays a […]
Appears in Issue 5
Tags: anti-angiogenic, BBSRC, Biotechnology and Biological Sciences Research Council, Bristol University, Cancer Biology Unit, Dr Sebastian Oltean, new drugs, Oncogene, Oncology, proangiogenic, Professor David Bates, prognosis, prostate cancer, Prostate Cancer UK, research, Richard Bright VEGF Research Trust, School of Medicine, signal protein vascular endothelial growth factor
November 2 2014 New research has shown a protein that controls the growth of new blood vessels […]
Appears in Issue 5
Tags: antiangiogenic VEGF, British Heart Foundation, Cancer Biology Unit, cardiovascular disease, Dr Shannon Amoils, leg amputation, National institutes of Health, Nature Medicine, new blood vessel growth, peripheral arterial disease, proangiogenic VEGF, Professor David Bates, research, signal protein vascular endothelial growth factor, symptomatic arterial disease